Millennium Management LLC Grows Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Millennium Management LLC lifted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 451.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 497,554 shares of the company’s stock after buying an additional 407,376 shares during the period. Millennium Management LLC owned approximately 0.40% of Henry Schein worth $34,431,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Palestra Capital Management LLC purchased a new position in shares of Henry Schein in the fourth quarter valued at about $182,988,000. Lyrical Asset Management LP bought a new stake in Henry Schein during the fourth quarter worth approximately $126,655,000. Norges Bank bought a new stake in Henry Schein during the fourth quarter worth approximately $103,301,000. Hudson Bay Capital Management LP increased its stake in Henry Schein by 102.1% during the fourth quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company’s stock worth $101,378,000 after acquiring an additional 740,007 shares during the last quarter. Finally, National Bank of Canada FI increased its stake in Henry Schein by 102.4% during the fourth quarter. National Bank of Canada FI now owns 1,084,511 shares of the company’s stock worth $75,048,000 after acquiring an additional 548,561 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a report on Wednesday, April 30th. StockNews.com downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. Wells Fargo & Company cut their target price on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Finally, Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $79.30.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.08% of the company’s stock.

Henry Schein Stock Up 0.7%

Shares of NASDAQ HSIC opened at $72.05 on Monday. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The firm has a fifty day moving average of $67.34 and a 200-day moving average of $71.47. The stock has a market capitalization of $8.77 billion, a PE ratio of 29.65, a P/E/G ratio of 2.13 and a beta of 0.87. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the previous year, the business posted $1.10 EPS. The firm’s revenue was down .1% compared to the same quarter last year. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.